iShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 9,300,000 shares, a decrease of 8.6% from the August 31st total of 10,180,000 shares. Based on an average daily volume of 1,257,200 shares, the days-to-cover ratio is currently 7.4 days.
iShares Biotechnology ETF Trading Up 0.5 %
Shares of NASDAQ:IBB opened at $145.60 on Tuesday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.57. The business’s fifty day moving average price is $145.69 and its two-hundred day moving average price is $138.91.
iShares Biotechnology ETF Announces Dividend
The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.
Institutional Inflows and Outflows
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Recommended Stories
- Five stocks we like better than iShares Biotechnology ETF
- How to Invest in Blue Chip Stocks
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Stock Analyst Ratings and Canadian Analyst Ratings
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Market Cap Calculator: How to Calculate Market Cap
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.